enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $67.16 million. The enterprise value is $29.20 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 17.54 million shares outstanding. The number of shares has increased by 36.65% in one year.
| Current Share Class | 17.54M |
| Shares Outstanding | 17.54M |
| Shares Change (YoY) | +36.65% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 23.94% |
| Float | 17.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 8.66 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.77, with a Debt / Equity ratio of 0.03.
| Current Ratio | 23.77 |
| Quick Ratio | 23.44 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.88% and return on invested capital (ROIC) is -35.07%.
| Return on Equity (ROE) | -52.88% |
| Return on Assets (ROA) | -34.07% |
| Return on Invested Capital (ROIC) | -35.07% |
| Return on Capital Employed (ROCE) | -59.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$576,486 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.40% in the last 52 weeks. The beta is 0.81, so enVVeno Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -23.40% |
| 50-Day Moving Average | 2.85 |
| 200-Day Moving Average | 3.58 |
| Relative Strength Index (RSI) | 73.90 |
| Average Volume (20 Days) | 77,507 |
Short Selling Information
The latest short interest is 393,076, so 2.24% of the outstanding shares have been sold short.
| Short Interest | 393,076 |
| Short Previous Month | 376,713 |
| Short % of Shares Out | 2.24% |
| Short % of Float | 2.26% |
| Short Ratio (days to cover) | 4.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.28M |
| Pretax Income | -20.60M |
| Net Income | -21.33M |
| EBITDA | -23.10M |
| EBIT | -23.28M |
| Earnings Per Share (EPS) | -$1.17 |
Full Income StatementBalance Sheet
The company has $38.94 million in cash and $979,000 in debt, giving a net cash position of $37.96 million or $2.16 per share.
| Cash & Cash Equivalents | 38.94M |
| Total Debt | 979,000 |
| Net Cash | 37.96M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 38.31M |
| Book Value Per Share | 2.18 |
| Working Capital | 37.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.31 million and capital expenditures -$27,000, giving a free cash flow of -$17.33 million.
| Operating Cash Flow | -17.31M |
| Capital Expenditures | -27,000 |
| Free Cash Flow | -17.33M |
| FCF Per Share | -$0.99 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |